Eryfotona SPF100+ - Fluid Facial Sunscreen for Actinic Keratosis 50 ml

If you have had actinic keratosis or non-melanoma skin cancer

You have or have had raised actinic skin lesions, with itching or scaling

If you have a family history of non-melanoma skin cancer

Prevents and improves the treatment of actinic skin lesions

Apply generously over the entire affected area and areas at risk (face, forehead, ears, scalp and backs of hands) twice a day, in the morning and at midday.

Daily use. Photolyase is activated by visible light.

In the event of direct exposure to the sun, reapply the product every two hours.

Apply to clean, intact skin.

Do not apply another dermatological or cosmetic product within 20 minutes of application.

For patients receiving drug treatment or who have undergone surgery to treat actinic keratosis or non-melanoma skin cancer, start Eryfotona treatment once the lesions have disappeared.

Daily use is essential as an adjunct to the prevention of actinic keratosis and non-melanoma skin cancers.

Actinic keratosis and other forms of non-melanoma skin cancer are diseases caused by chronic sun exposure.

If you suffer from actinic keratosis or non-melanoma skin cancer, we recommend that you avoid direct exposure to the sun.

We do not recommend its use for children, pregnant women or while breastfeeding.

Avoid contact with eyes and mucous membranes.

If a possible adverse reaction to one of the ingredients occurs, stop treatment and consult your doctor or dermatologist.

Keep out of the sight and reach of children.

Shake the bottle before use.

$url('Search-Show','cgid','isdin')$

Repairsomes® (UVB-UVA Filter complex+ plankton extract), Bisabolol, Tocopheryl acetate, Panthenol, Excipients qs